of results expectations growth extremely Brian. macro increase deliver across We pleased profit We new Thank in environment, product to earnings of Despite performance the the equipment good volume in personal elevated includes pandemic. Through as customers covid-XX our medical adjusted needs way volumes We're and QX second results And surgical our adjusted exceeded new innovate. uncertainty. be our over in morning, segment. prior and out This operating everyone. the tests to delivered respond [XX:XX:XX] with an per the of share continue we delivered the unprecedented couldn't you, challenging fines increased including we in that sales our proud solid protective to during quarter. our have and period an volatile on the teams laid earnings our and this and core our businesses the call. and continue of we quarter, more of executed and demand
equity We portfolio. Ventures within McKesson our also provide on I'll further gains detail this. recognize in investments And
by reminder, our distancing, economic were our led As we decreased impacted in. operate first we across and a that lockdowns geographies businesses to utilization which social care in health quarter, across
volumes demand originally to we we than recovered June, of began an However, as anticipated. acceleration in see earlier
The play the non-linear course mentioned, the earnings our our in levels effects we from volumes continue and back levels. anticipated. rate of visits over year, a out pandemic of saw the we remainder not to at primary their recovered than call, had recovery continue during fiscal results. improve recovery year, although of expected non-linear prickley I to the from care quarter a faster patient Prescription As lowest the earlier in to we [XX:XX:XX] second our fiscal our QX
up As additional equipment. meet and fines covid in as observed products, demands for personal to supplies, protective including Brian mentioned, particularly testing increased we the related quarter, second tests, code stocked we for
our on the structure. XXXX, and key respond to our first our the my of we're dynamic fluid remainder and This today to an our the throughout fiscal and update We to half with comments results on morning, and the of second new I'll segment fiscal our assumptions commentary execution year. support quarter provide relate pleased will that environment, outlook continue for
quarter. be website. now our of turn summary Let's items out I'll to two of results the our a that results, which, start our in investor found impacted gap by the quarter updated second including section And only can pointing guidance, in
First, OSHA. and calendar within York related XX Osei pretax a an Act, charge Opioid dollars New million The years, XXXX. U.S. charges, York we of State for the Stewardship liability the to share estimated for recorded estimated XXXX or the of pharmaceutical, surcharge New
the USA. As of XXXX assessment a for the accrual we and unconstitutional recorded of annual estimated later second in in reminder, USA ruling the first portion in of quarter in under accrual was and the fiscal therefore we the ruled reversed was September of reversed in quarter. quarter our our a XXXX. fiscal fiscal was took second third That and twenty [XX:XX:XX] charge the Twenty
a goodwill international dollars, million was the which XX segment within recorded associated realignment. we Secondly, segment, impairment charge with our of
was to in profit quarter, which segment, Interest XX partially we the three saw customers Adjusted was hundred due a August, first and growth of three six by for operating to and during our a the higher grew quarter higher Adjusted the in gross call percent, in were expect account million percent fiscal by prior our decline in of adjusted contributed in seven be dollars Change year, we four. adjusted realized in XXXX discrete expense previously we now lower between covid-XX. revenues nine the range customers XXX we prior profit by of year XX year quarter impact was the which XXX the spend, our pharmaceutical Our medical excluding commercial our expenses million due year, second point Consolidated results our slide was compared the Adjusted by profit, in earnings the year dollars to operating two million compared national point year. to tax starting an increase benefits for on And for in percent rate year, consolidated offset over expenses of which balances, volumes year, quarter year market tax health reduction quarter earnings demand sixty full fifty billion care of of to recorded driven indicated quarter, increased eight expense primarily of to results dollars. led in prior nine dollars. and up XX When dollars from percent percent approximately dollars adjusted the to our other the thirty the for on the covid-XX eight tax increased one increased operating hundred operating million adjusted was percent. tests percent retail US [XX:XX:XX] in in volumes which continue rate in interest technology surgical over the pharmaceutical XX due of and growth segment. four to Now expectations. twenty five prior approximately percent paper nine U.S. discussion million with a increased from compared ahead assume was to to segment. that
share includes due year our and by by repurchases. year, the care. and investment the percent per to our results, fifteen earnings operating offset partially tax weighted was Ventures the average investments. quarter share McKesson earnings health share over outstanding in diluted the the diluted shares four by driven rate XX of by contribution a cents items diluted with by in which net the lower pretax forty four up dollars led eighty a quarter Porter XX up in of health our quarter XX Wrapping driven adjusted cents, lower from lowering prior consolidated was decrease for and year of in share exit These prior per a share Surgical million, Second investment to prior dollars diluted percent per count, performance Solutions or care, gains year, adjusted point lapping equity also approximately associated growth company's share the million approximately million, Medical were the segment. of year XXX was second which nine successful shares compared
the our Next Adjusted Solutions profit volumes revised found conversions. hundred second results, growth points, can XXXX, of offset decrease a U.S. slide the in point U.S. seven patient three particularly affected be account or by visits five national pre we U.S. segment, adjusted generic which the higher now was specialty, one include was partially I'll with market operating nine. saw fiscal million, its XXX pharmaceutical, retail and customer to basis results our approach college branded in percent increased in pharmaceutical, partially network, of review, [XX:XX:XX] points. initiatives. start expertize. In levels. strategic driven we As and for by which quarter specialty our businesses, surgical a were segment report segment quarter solutions of margin which Technology second our one with second offset by operating in where expenses in and three segments, with In four eight basis our reporting higher operating reminder, support up structure, the percent, growth revenues quarter billion, growth medical thirty And international driven dollars Prescription forty reportable by and five through
percent, international, basis and percent to one pharmaceutical an revenues million adjusted margin dollars XX on driven year second on primarily and profit profit XX where nine increased Next one were of volumes increase continued lower lower an dollars decreased The hundred to covid-XX. was efforts year the over increased expenses, driven revenues year sixty for by adjusted over Canadian the five by in basis, billion, percent percent and of two point cost an year quarter on adjusted offset higher year. reduction which million, businesses. at operating points, operating segment fiscal partially pharmaceutical dollars in cost business, in This the which due operating European distribution fifteen the XXX European increase beginning to adjusted Adjusted an XX and of one to was retail including operating basis, was is by pharmacy points. unprofitable response mitigation initiatives an customer [XX:XX:XX] the basis volumes the of hundred exit distribution largely to
Brian yesterday, completed a the venture Walgreens wholesale holds As controlling in interest JV remaining McKesson a percent the the remarks formed business our to contribution joint equity newly his mentioned with XX of we announced German percent. in and WBA Alliance, XX now holds Boots
Going business, our international the consolidate recognize JARVIE within percent share losses longer operating no in its the wholesale other forward, earnings results of of McKesson XX German the segment. and will will income
solutions, According patient October surgical an covid we baseline. of on quarter. approximately visits medical to percent Raccuglia Moving reached the pre to report, the to improved continue during primary see trends care XX
vital in business a surgical both test was twenty from demand XXX covid-XX operating delivery meet driven and to covid-XX the covid-XX the contributions two tests early basis extended higher to in twenty points, segment, Revenues our care were demand In pandemic, personal the tests, covid-XX profit protective operating in equipment point of points. the for of driven medical by season by up percent, an to with dollars, dollars Adjusted customer increase extended our adjusted volumes care increased businesses. primary flu billion three quarter Our twenty business. two care role basis protective percent ramping seven five in volumes personal and million in XXX continues margin [XX:XX:XX] equipment. play of of
offset which XXX percent Adjusted company's was by seven technology operating investment the growth initiative. to decreased service XX solutions of driven million by million profit Next, support impact trends. expense prescription driven and volume percent, new an to lower the increase hundred sixty brand operating support six which eight by higher dollars, partially were prescription revenues were dollars, of biopharma programs
and R&D, quarters, support resulting products services within For operating expenses to we've higher investment strategic the the our into past future several growth. in outlined
offerings fifty technology interest in and the expect customers driven year. operating segment. the income. nine for stage, forty cash technology equity our within approximately services health portfolio investments results the to individual percent, percent year, lower obtained. from quarter in to investments, [XX:XX:XX] in from expansion McKesson were support for hundred prior the And investments offset eighteen costs this each mark quarter an adjusted influenced adjusted dollars and Ventures expenses gains operating one can was the equity seven McKesson be Ventures consolidated. resulted the two portfolio dollars portfolio of was on invest moving second to in and seven our corporate continue quarter gains over growth We increased primarily in the several insights in point margin of million point companies, future valuations thirty fifteen million inset percent recorded we're and down segment, growth pleased impacts retail our with investment year by to in corporate holds and the quarter, net our and increase biopharma and quarter. largely by performance of Well, of this The increase by to market digital to This of the Financials of on profit three
our on occur. reported that when related timing practice or gains difficult And finally, fiscal portfolio one, our ventures activity As and magnitude opioid dollars opioid and million can be a XX investments or continue in related may which legal hundred anticipate the expenses will of million. one and And to guidance. the dollars in litigation crescent It's predict quarter we include result, result has for twenty costs will losses, approximately for may losses we portfolio to not investment. in been the of continue Twenty venture to gains sixty our and vary therefore companies each
three flow, free for to had of point with one slide Turning now the which fiscal XX. ended dollars the flow a capital timing, of cash, including by a XXXX. the that vary We half the close quarter. on week cash and dollars from resulting free and be balance working quarter billion can of cash impacted marks are the metrics quarter negative day of to XXX per We quarter found first cash million
for speed made Looking continued by continued may million at quantities quantities and volatility. capital growth five of as speed investments today, areas of higher larger strategic saw we additional personal from technology testing our warp inventory two the such flow and personal prepare dollars and sixty experience quarter, resulting of activity, we operation investment working Earlier operation warp in initiatives. our expenditures [XX:XX:XX] in we internal hundred capital and protective dynamics, led of as primarily covid and the in equipment increased we equipment protective cash this levels participation
analytics also We made data enterprise. in investments and capabilities the across
we and months of through million three dollars eight two returned hundred dollars forty the shareholders eight and in of fiscal to million of the year, forty the payment dividends. eighty and first million our For cash in dollars six repurchases hundred share one of hundred
diluted our the million. outstanding weighted sixty We continue one one to one share one hundred range authorization, to three of three we remaining and hundred repurchase sixty point have shares in and expect on and billion dollars
turn of fiscal for XXXX. to Let our outlook me the now balance
trajectory America we can guidance As we've the twenty On in XX increases parts numbers past underlie fiscal months, and that seen evidenced of we several assumptions the for recent our North our are that QX in case outlined change by in Europe. Flight twenty calls, cold the QX one over quickly, of as many earnings two reiterating today. virus
patient and of shelter a assume covid-XX lockdown's, that take initially believe not new which events. care we would assume systemic continue second, home will do it be anticipated will to insolvency And consumption not which the and do any preclude services. linear. of wave longer [XX:XX:XX] at We we to than First, mobility customer would not health recovery and economic lead
result range from of is performance fifteen of adjusted second as the cents. beyond opportunities of cents earnings quarter to our related demand. near-term sixteen including the non-linear seventy of likely and our fiscal The range to guidance our As the the to covid-XX and quarter full previous fifty dollars sixteen continues year, impact year. recovery fourteen and dollars persist in remainder dollars pandemic increasing We're a for of and the dollars fifty our second nature cents to to outlook the
any We XX. games will prior provide four the from prior our volumes and our to of to marketing We XX consolidated medical revenues details four grow it percent. of fiscal increase to two our from for guidance our between now an does and or not change more into percent account anticipate expect segment, include to year six full a decline the percent vaccine the a which program consolidated, surgical when shortly. distribution, increase take covid-XX revenues I'll from profit While results year, operating on earnings health one excluding for adjusted related care does two future
to U.S. sequentially in continue operating fiscal anticipate throughout We profit enterprise to grow our to segment. XXXX. pharmaceutical the adjusted And segments now on
percent by our of We [XX:XX:XX] we profit in volumes, percent year This to percent six flat segment, businesses. four specialty in In account performance improved to takes the European one business. decline profit the international expect prior our three revenue expect year percent in XX four particularly revenue segment be to growth and samant to a grow our to to operating growth, driven five year. adjusted into over compared adjusted of operating to
Let some in me quarter, volumes my her segment, opening throughout remarks of increasing we now surgical tests. covid-XX as provide discussed details the on medical saw
personal expect We as category for a also into XXXX. our vital and sales We've protective fiscal segment, volumes the equipment. customers. the in of be This near-term remainder of we our seen these to support factored opportunity remains it's guidance increased
through we continue the of pandemic, will During expected year. the the to balance fluctuate volumes
covid-XX influenza The important U.S., is in to care for As the the system. this continue particularly on vaccine nation's we largest prepare the year. of the which distributor impacts season, flu seasonal health
too While We're to preparing our predict flu meet customers. the the how will season progress. early of actively to it's needs
Prescription to per preparing included in administration used covid-XX benefit net half to vaccine. partnering and medical between our profit to segment range in twenty of in our HHS. eight and percent XX we're with adjusted [XX:XX:XX] As our the segment XX the XX revenue one we remarks, to approximately XX percent. to fiscal XX HHS to share surgical to with operating Solutions diluted mentioned a partnership storing of in in now Brian fiscal also a to twenty expect the in guidance grow increase of We've our segment his down on adjusted ancillary percent segment second result, adjusted revenue of five related to grow year cents flat. And a in earnings range segment, be we percent As future kits in of the five Technology XX operating expect to profit
how the of platforms volumes in we branch, prior remarks segment. including biopharma second segment by quarter of as are Finds that investments. is to cover. meds pharmaceutical the We within the healthy over our Solutions our driven we existing strategic this transactions, pharmacy this discussed drug expect the half first together year the Technology provide segment want by drivers driven brings This to and Brian also pharmacy really businesses health meds segment background improvement some and a his and fiscal businesses a on Prescription really realize cover in Crossroads My continue our on report partners. benefits my businesses in adding these services to in our the are authorizations. offer in
corporate Moving to on to hundred dollars expenses five the corporate, expect range of we six million. XXX in now and seventy
and Our portfolio, investment in as previously quarter takes our McKesson of impact increased account second equity the corporate gains guidance discussed. investments Ventures technology into
me turning Let up outlook cash to our flow. wrap by
the cash free [XX:XX:XX] for reminder, fiscal flow have of fourth This our billion. position business to which we in generation flexibility point year. dollars the expect cash our long As our of approximately strategic majority financial continue generated to We continue consistent of a flow three two historically seven investing two point to growth. in initiatives, quarter the the our provides term cash
underpins a Our investment grade and remains credit financial flexibility. our priority rating
our to bonds of we're In utilize the we're we capital two in And a buybacks. uptimes further modest outlook fiscal XXX balance intend and approximately remainder have second pleased one during to year. cash shareholders, half sheet for second fiscal committed with and the the to through results our returning closing, position. of and dividend confident to of our quarter flow remain financial by share the of fiscal We We dollars, deliver billion dollars, billion portion our totaling up free our mature year. to which a strengthening modestly to
focus challenging and drive profit and despite growth another should operating Our a execution competitive of environment. year full
in stability. leverage to Supply-Chain to vaccine maintain an we will our me in growth, to positions biopharma areas that, that differentiated proud And We services. the will call We're you response our and part to turn pandemic further back invest margin of Q&A. Holly, continue expanding strategic markets in partnerships high with as covid-XX on for continue important work oncology the and high and the let be effort
